Found 4 hits for monomerid = 50128073 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Kappa-type opioid receptor
(Homo sapiens (Human)) | BDBM50128073
(CHEMBL2369365 | Tyr-Gly-Pro-Phe-Leu-Arg-Arg-Ile-Ar...)Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccccc1)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](-[#7])=O Show InChI InChI=1S/C61H101N23O11/c1-5-35(4)48(57(95)80-42(18-11-27-74-60(68)69)51(89)77-40(49(63)87)16-9-25-72-58(64)65)83-53(91)43(19-12-28-75-61(70)71)78-52(90)41(17-10-26-73-59(66)67)79-54(92)44(30-34(2)3)81-55(93)45(32-36-14-7-6-8-15-36)82-56(94)46-20-13-29-84(46)47(86)33-76-50(88)39(62)31-37-21-23-38(85)24-22-37/h6-8,14-15,21-24,34-35,39-46,48,85H,5,9-13,16-20,25-33,62H2,1-4H3,(H2,63,87)(H,76,88)(H,77,89)(H,78,90)(H,79,92)(H,80,95)(H,81,93)(H,82,94)(H,83,91)(H4,64,65,72)(H4,66,67,73)(H4,68,69,74)(H4,70,71,75)/t35-,39-,40+,41-,42-,43-,44-,45-,46?,48-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 3.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of California
Curated by ChEMBL
| Assay Description In vitro binding affinity towards human Opioid receptor kappa 1 on CHO cell membranes using [3H]diprenorphine displacement. |
J Med Chem 46: 2104-9 (2003)
Article DOI: 10.1021/jm020125+ BindingDB Entry DOI: 10.7270/Q2NZ88CF |
More data for this Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM50128073
(CHEMBL2369365 | Tyr-Gly-Pro-Phe-Leu-Arg-Arg-Ile-Ar...)Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccccc1)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](-[#7])=O Show InChI InChI=1S/C61H101N23O11/c1-5-35(4)48(57(95)80-42(18-11-27-74-60(68)69)51(89)77-40(49(63)87)16-9-25-72-58(64)65)83-53(91)43(19-12-28-75-61(70)71)78-52(90)41(17-10-26-73-59(66)67)79-54(92)44(30-34(2)3)81-55(93)45(32-36-14-7-6-8-15-36)82-56(94)46-20-13-29-84(46)47(86)33-76-50(88)39(62)31-37-21-23-38(85)24-22-37/h6-8,14-15,21-24,34-35,39-46,48,85H,5,9-13,16-20,25-33,62H2,1-4H3,(H2,63,87)(H,76,88)(H,77,89)(H,78,90)(H,79,92)(H,80,95)(H,81,93)(H,82,94)(H,83,91)(H4,64,65,72)(H4,66,67,73)(H4,68,69,74)(H4,70,71,75)/t35-,39-,40+,41-,42-,43-,44-,45-,46?,48-/m0/s1 | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 2.34E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of California
Curated by ChEMBL
| Assay Description In vitro binding affinity to human Opioid receptor mu 1 on CHO cell membranes using [3H]diprenorphine displacement. |
J Med Chem 46: 2104-9 (2003)
Article DOI: 10.1021/jm020125+ BindingDB Entry DOI: 10.7270/Q2NZ88CF |
More data for this Ligand-Target Pair | |
Delta-type opioid receptor
(Homo sapiens (Human)) | BDBM50128073
(CHEMBL2369365 | Tyr-Gly-Pro-Phe-Leu-Arg-Arg-Ile-Ar...)Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccccc1)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](-[#7])=O Show InChI InChI=1S/C61H101N23O11/c1-5-35(4)48(57(95)80-42(18-11-27-74-60(68)69)51(89)77-40(49(63)87)16-9-25-72-58(64)65)83-53(91)43(19-12-28-75-61(70)71)78-52(90)41(17-10-26-73-59(66)67)79-54(92)44(30-34(2)3)81-55(93)45(32-36-14-7-6-8-15-36)82-56(94)46-20-13-29-84(46)47(86)33-76-50(88)39(62)31-37-21-23-38(85)24-22-37/h6-8,14-15,21-24,34-35,39-46,48,85H,5,9-13,16-20,25-33,62H2,1-4H3,(H2,63,87)(H,76,88)(H,77,89)(H,78,90)(H,79,92)(H,80,95)(H,81,93)(H,82,94)(H,83,91)(H4,64,65,72)(H4,66,67,73)(H4,68,69,74)(H4,70,71,75)/t35-,39-,40+,41-,42-,43-,44-,45-,46?,48-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 6.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of California
Curated by ChEMBL
| Assay Description In vitro binding affinity to human Opioid receptor delta 1 on CHO cell membranes using [3H]diprenorphine displacement. |
J Med Chem 46: 2104-9 (2003)
Article DOI: 10.1021/jm020125+ BindingDB Entry DOI: 10.7270/Q2NZ88CF |
More data for this Ligand-Target Pair | |
Kappa-type opioid receptor
(Homo sapiens (Human)) | BDBM50128073
(CHEMBL2369365 | Tyr-Gly-Pro-Phe-Leu-Arg-Arg-Ile-Ar...)Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccccc1)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](-[#7])=O Show InChI InChI=1S/C61H101N23O11/c1-5-35(4)48(57(95)80-42(18-11-27-74-60(68)69)51(89)77-40(49(63)87)16-9-25-72-58(64)65)83-53(91)43(19-12-28-75-61(70)71)78-52(90)41(17-10-26-73-59(66)67)79-54(92)44(30-34(2)3)81-55(93)45(32-36-14-7-6-8-15-36)82-56(94)46-20-13-29-84(46)47(86)33-76-50(88)39(62)31-37-21-23-38(85)24-22-37/h6-8,14-15,21-24,34-35,39-46,48,85H,5,9-13,16-20,25-33,62H2,1-4H3,(H2,63,87)(H,76,88)(H,77,89)(H,78,90)(H,79,92)(H,80,95)(H,81,93)(H,82,94)(H,83,91)(H4,64,65,72)(H4,66,67,73)(H4,68,69,74)(H4,70,71,75)/t35-,39-,40+,41-,42-,43-,44-,45-,46?,48-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of California
Curated by ChEMBL
| Assay Description In vitro binding affinity towards human Opioid receptor kappa 1 on CHO cell membranes using [3H]diprenorphine displacement. |
J Med Chem 46: 2104-9 (2003)
Article DOI: 10.1021/jm020125+ BindingDB Entry DOI: 10.7270/Q2NZ88CF |
More data for this Ligand-Target Pair | |